Here, we showed that systemic Mocetinostat administration to CHF animals reduced the expression of ECM components collagen and fibronectin and their regulators such as Timp-1 in cardiac fibroblasts in vivo. This evidence concerns the gene TIMP1 and congestive heart failure.